nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—Mitomycin—urinary bladder cancer	0.263	0.474	CbGbCtD
Acebutolol—ABCB1—Gemcitabine—urinary bladder cancer	0.0758	0.136	CbGbCtD
Acebutolol—ABCB1—Cisplatin—urinary bladder cancer	0.055	0.0991	CbGbCtD
Acebutolol—ABCB1—Etoposide—urinary bladder cancer	0.0541	0.0973	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—urinary bladder cancer	0.0369	0.0664	CbGbCtD
Acebutolol—ABCB1—Methotrexate—urinary bladder cancer	0.0357	0.0643	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—urinary bladder cancer	0.0348	0.0626	CbGbCtD
Acebutolol—Decreased appetite—Cisplatin—urinary bladder cancer	0.000561	0.00126	CcSEcCtD
Acebutolol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000561	0.00126	CcSEcCtD
Acebutolol—Pneumonia—Methotrexate—urinary bladder cancer	0.000559	0.00126	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000557	0.00125	CcSEcCtD
Acebutolol—Drowsiness—Methotrexate—urinary bladder cancer	0.000555	0.00125	CcSEcCtD
Acebutolol—Depression—Methotrexate—urinary bladder cancer	0.000554	0.00125	CcSEcCtD
Acebutolol—Hypotension—Etoposide—urinary bladder cancer	0.000553	0.00124	CcSEcCtD
Acebutolol—Pain—Cisplatin—urinary bladder cancer	0.000552	0.00124	CcSEcCtD
Acebutolol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000548	0.00123	CcSEcCtD
Acebutolol—Dysuria—Epirubicin—urinary bladder cancer	0.000545	0.00123	CcSEcCtD
Acebutolol—Dizziness—Thiotepa—urinary bladder cancer	0.000544	0.00122	CcSEcCtD
Acebutolol—Urticaria—Fluorouracil—urinary bladder cancer	0.000541	0.00122	CcSEcCtD
Acebutolol—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00054	0.00121	CcSEcCtD
Acebutolol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000538	0.00121	CcSEcCtD
Acebutolol—Sweating—Methotrexate—urinary bladder cancer	0.000533	0.0012	CcSEcCtD
Acebutolol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000532	0.0012	CcSEcCtD
Acebutolol—Paraesthesia—Etoposide—urinary bladder cancer	0.000531	0.00119	CcSEcCtD
Acebutolol—Weight increased—Epirubicin—urinary bladder cancer	0.000531	0.00119	CcSEcCtD
Acebutolol—Dyspnoea—Etoposide—urinary bladder cancer	0.000527	0.00119	CcSEcCtD
Acebutolol—Somnolence—Etoposide—urinary bladder cancer	0.000526	0.00118	CcSEcCtD
Acebutolol—Vomiting—Thiotepa—urinary bladder cancer	0.000524	0.00118	CcSEcCtD
Acebutolol—Pneumonia—Epirubicin—urinary bladder cancer	0.000523	0.00118	CcSEcCtD
Acebutolol—Drowsiness—Epirubicin—urinary bladder cancer	0.00052	0.00117	CcSEcCtD
Acebutolol—Rash—Thiotepa—urinary bladder cancer	0.000519	0.00117	CcSEcCtD
Acebutolol—Dermatitis—Thiotepa—urinary bladder cancer	0.000519	0.00117	CcSEcCtD
Acebutolol—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000518	0.00117	CcSEcCtD
Acebutolol—Headache—Thiotepa—urinary bladder cancer	0.000516	0.00116	CcSEcCtD
Acebutolol—Decreased appetite—Etoposide—urinary bladder cancer	0.000514	0.00116	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000511	0.00115	CcSEcCtD
Acebutolol—Body temperature increased—Cisplatin—urinary bladder cancer	0.00051	0.00115	CcSEcCtD
Acebutolol—Fatigue—Etoposide—urinary bladder cancer	0.00051	0.00115	CcSEcCtD
Acebutolol—Constipation—Etoposide—urinary bladder cancer	0.000506	0.00114	CcSEcCtD
Acebutolol—Pain—Etoposide—urinary bladder cancer	0.000506	0.00114	CcSEcCtD
Acebutolol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000505	0.00114	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—urinary bladder cancer	0.000504	0.00113	CcSEcCtD
Acebutolol—Sweating—Epirubicin—urinary bladder cancer	0.000498	0.00112	CcSEcCtD
Acebutolol—Asthenia—Gemcitabine—urinary bladder cancer	0.000497	0.00112	CcSEcCtD
Acebutolol—Pharyngitis—Methotrexate—urinary bladder cancer	0.000495	0.00111	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—urinary bladder cancer	0.000491	0.0011	CcSEcCtD
Acebutolol—Pruritus—Gemcitabine—urinary bladder cancer	0.00049	0.0011	CcSEcCtD
Acebutolol—Nausea—Thiotepa—urinary bladder cancer	0.000489	0.0011	CcSEcCtD
Acebutolol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000487	0.0011	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000485	0.00109	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—urinary bladder cancer	0.000484	0.00109	CcSEcCtD
Acebutolol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000484	0.00109	CcSEcCtD
Acebutolol—Pruritus—Fluorouracil—urinary bladder cancer	0.000482	0.00108	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—urinary bladder cancer	0.000481	0.00108	CcSEcCtD
Acebutolol—Visual impairment—Methotrexate—urinary bladder cancer	0.000481	0.00108	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—urinary bladder cancer	0.000475	0.00107	CcSEcCtD
Acebutolol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000474	0.00107	CcSEcCtD
Acebutolol—Urticaria—Etoposide—urinary bladder cancer	0.00047	0.00106	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—urinary bladder cancer	0.000468	0.00105	CcSEcCtD
Acebutolol—Body temperature increased—Etoposide—urinary bladder cancer	0.000468	0.00105	CcSEcCtD
Acebutolol—Abdominal pain—Etoposide—urinary bladder cancer	0.000468	0.00105	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000468	0.00105	CcSEcCtD
Acebutolol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000466	0.00105	CcSEcCtD
Acebutolol—Tinnitus—Methotrexate—urinary bladder cancer	0.000465	0.00105	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000464	0.00104	CcSEcCtD
Acebutolol—Asthenia—Cisplatin—urinary bladder cancer	0.000463	0.00104	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—urinary bladder cancer	0.000463	0.00104	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—urinary bladder cancer	0.000461	0.00104	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000459	0.00103	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—urinary bladder cancer	0.000452	0.00102	CcSEcCtD
Acebutolol—Dizziness—Fluorouracil—urinary bladder cancer	0.00045	0.00101	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—urinary bladder cancer	0.00045	0.00101	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000449	0.00101	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000449	0.00101	CcSEcCtD
Acebutolol—Chills—Methotrexate—urinary bladder cancer	0.000447	0.00101	CcSEcCtD
Acebutolol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000442	0.000994	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—urinary bladder cancer	0.000441	0.000991	CcSEcCtD
Acebutolol—Vomiting—Gemcitabine—urinary bladder cancer	0.00044	0.000991	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.00044	0.000989	CcSEcCtD
Acebutolol—Rash—Gemcitabine—urinary bladder cancer	0.000437	0.000983	CcSEcCtD
Acebutolol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000436	0.000982	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—urinary bladder cancer	0.000435	0.000979	CcSEcCtD
Acebutolol—Headache—Gemcitabine—urinary bladder cancer	0.000434	0.000976	CcSEcCtD
Acebutolol—Flushing—Epirubicin—urinary bladder cancer	0.000433	0.000974	CcSEcCtD
Acebutolol—Vomiting—Fluorouracil—urinary bladder cancer	0.000433	0.000974	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—urinary bladder cancer	0.000433	0.000974	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00043	0.000967	CcSEcCtD
Acebutolol—Rash—Fluorouracil—urinary bladder cancer	0.000429	0.000966	CcSEcCtD
Acebutolol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000429	0.000965	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000429	0.000964	CcSEcCtD
Acebutolol—Headache—Fluorouracil—urinary bladder cancer	0.000427	0.00096	CcSEcCtD
Acebutolol—Asthenia—Etoposide—urinary bladder cancer	0.000424	0.000955	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000424	0.000955	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—urinary bladder cancer	0.000423	0.000953	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000421	0.000946	CcSEcCtD
Acebutolol—Back pain—Methotrexate—urinary bladder cancer	0.00042	0.000945	CcSEcCtD
Acebutolol—Chills—Epirubicin—urinary bladder cancer	0.000419	0.000942	CcSEcCtD
Acebutolol—Pruritus—Etoposide—urinary bladder cancer	0.000418	0.000941	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—urinary bladder cancer	0.000416	0.000936	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—urinary bladder cancer	0.000412	0.000928	CcSEcCtD
Acebutolol—Nausea—Gemcitabine—urinary bladder cancer	0.000411	0.000926	CcSEcCtD
Acebutolol—Vomiting—Cisplatin—urinary bladder cancer	0.00041	0.000923	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—urinary bladder cancer	0.000409	0.00092	CcSEcCtD
Acebutolol—Rash—Cisplatin—urinary bladder cancer	0.000407	0.000916	CcSEcCtD
Acebutolol—Dermatitis—Cisplatin—urinary bladder cancer	0.000407	0.000915	CcSEcCtD
Acebutolol—Diarrhoea—Etoposide—urinary bladder cancer	0.000405	0.00091	CcSEcCtD
Acebutolol—Nausea—Fluorouracil—urinary bladder cancer	0.000405	0.00091	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000403	0.000906	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—urinary bladder cancer	0.000403	0.000906	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—urinary bladder cancer	0.000401	0.000902	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—urinary bladder cancer	0.0004	0.000901	CcSEcCtD
Acebutolol—Back pain—Epirubicin—urinary bladder cancer	0.000393	0.000884	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—urinary bladder cancer	0.000392	0.000881	CcSEcCtD
Acebutolol—Malaise—Methotrexate—urinary bladder cancer	0.000391	0.000881	CcSEcCtD
Acebutolol—Dizziness—Etoposide—urinary bladder cancer	0.000391	0.00088	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—urinary bladder cancer	0.00039	0.000877	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000389	0.000875	CcSEcCtD
Acebutolol—Chills—Doxorubicin—urinary bladder cancer	0.000387	0.000872	CcSEcCtD
Acebutolol—Nausea—Cisplatin—urinary bladder cancer	0.000383	0.000863	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—urinary bladder cancer	0.000383	0.000861	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—urinary bladder cancer	0.000382	0.000858	CcSEcCtD
Acebutolol—Cough—Methotrexate—urinary bladder cancer	0.000379	0.000852	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000377	0.000848	CcSEcCtD
Acebutolol—Vomiting—Etoposide—urinary bladder cancer	0.000376	0.000846	CcSEcCtD
Acebutolol—Rash—Etoposide—urinary bladder cancer	0.000373	0.000839	CcSEcCtD
Acebutolol—Dermatitis—Etoposide—urinary bladder cancer	0.000373	0.000838	CcSEcCtD
Acebutolol—Headache—Etoposide—urinary bladder cancer	0.000371	0.000834	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—urinary bladder cancer	0.00037	0.000833	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—urinary bladder cancer	0.00037	0.000831	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—urinary bladder cancer	0.00037	0.000831	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—urinary bladder cancer	0.00037	0.000831	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000367	0.000826	CcSEcCtD
Acebutolol—Malaise—Epirubicin—urinary bladder cancer	0.000366	0.000824	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—urinary bladder cancer	0.000365	0.000821	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—urinary bladder cancer	0.000365	0.000821	CcSEcCtD
Acebutolol—Syncope—Epirubicin—urinary bladder cancer	0.000364	0.00082	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—urinary bladder cancer	0.000364	0.000818	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—urinary bladder cancer	0.000359	0.000808	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—urinary bladder cancer	0.000357	0.000804	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000357	0.000803	CcSEcCtD
Acebutolol—Cough—Epirubicin—urinary bladder cancer	0.000354	0.000798	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—urinary bladder cancer	0.000354	0.000797	CcSEcCtD
Acebutolol—Nausea—Etoposide—urinary bladder cancer	0.000351	0.00079	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000349	0.000785	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000347	0.000782	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—urinary bladder cancer	0.000346	0.000778	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—urinary bladder cancer	0.000346	0.000778	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—urinary bladder cancer	0.000346	0.000778	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—urinary bladder cancer	0.000345	0.000775	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—urinary bladder cancer	0.000344	0.000774	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000343	0.000773	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000342	0.000771	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—urinary bladder cancer	0.000342	0.000769	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—urinary bladder cancer	0.000339	0.000763	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—urinary bladder cancer	0.000338	0.00076	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—urinary bladder cancer	0.000338	0.00076	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—urinary bladder cancer	0.000337	0.000758	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—urinary bladder cancer	0.000334	0.000752	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—urinary bladder cancer	0.000332	0.000747	CcSEcCtD
Acebutolol—Oedema—Epirubicin—urinary bladder cancer	0.000332	0.000746	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—urinary bladder cancer	0.000331	0.000745	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00033	0.000743	CcSEcCtD
Acebutolol—Cough—Doxorubicin—urinary bladder cancer	0.000328	0.000738	CcSEcCtD
Acebutolol—Shock—Epirubicin—urinary bladder cancer	0.000326	0.000734	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000325	0.000731	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000323	0.000726	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—urinary bladder cancer	0.000322	0.000725	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000321	0.000721	CcSEcCtD
Acebutolol—Insomnia—Methotrexate—urinary bladder cancer	0.00032	0.000721	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—urinary bladder cancer	0.00032	0.00072	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—urinary bladder cancer	0.00032	0.00072	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—urinary bladder cancer	0.00032	0.00072	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—urinary bladder cancer	0.000319	0.000717	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000318	0.000716	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000318	0.000715	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—urinary bladder cancer	0.000316	0.000711	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—urinary bladder cancer	0.000316	0.000711	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000316	0.000711	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—urinary bladder cancer	0.000315	0.000709	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000312	0.000702	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—urinary bladder cancer	0.00031	0.000697	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—urinary bladder cancer	0.000309	0.000696	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000308	0.000693	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—urinary bladder cancer	0.000307	0.00069	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000306	0.000688	CcSEcCtD
Acebutolol—Fatigue—Methotrexate—urinary bladder cancer	0.000305	0.000687	CcSEcCtD
Acebutolol—Pain—Methotrexate—urinary bladder cancer	0.000303	0.000682	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000302	0.00068	CcSEcCtD
Acebutolol—Shock—Doxorubicin—urinary bladder cancer	0.000302	0.000679	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000301	0.000677	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—urinary bladder cancer	0.0003	0.000675	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000298	0.00067	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000298	0.00067	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000297	0.000667	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000296	0.000665	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—urinary bladder cancer	0.000295	0.000663	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—urinary bladder cancer	0.000292	0.000658	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000292	0.000657	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000292	0.000657	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00029	0.000652	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000288	0.000648	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—urinary bladder cancer	0.000287	0.000645	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000286	0.000644	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—urinary bladder cancer	0.000286	0.000643	CcSEcCtD
Acebutolol—Constipation—Epirubicin—urinary bladder cancer	0.000284	0.000638	CcSEcCtD
Acebutolol—Pain—Epirubicin—urinary bladder cancer	0.000284	0.000638	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—urinary bladder cancer	0.000281	0.000633	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—urinary bladder cancer	0.00028	0.00063	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—urinary bladder cancer	0.00028	0.00063	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000279	0.000629	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—urinary bladder cancer	0.000277	0.000624	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000275	0.00062	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000273	0.000615	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000273	0.000615	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—urinary bladder cancer	0.000273	0.000614	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000271	0.00061	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00027	0.000608	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000267	0.0006	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000265	0.000596	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—urinary bladder cancer	0.000264	0.000595	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—urinary bladder cancer	0.000263	0.000593	CcSEcCtD
Acebutolol—Pain—Doxorubicin—urinary bladder cancer	0.000262	0.00059	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—urinary bladder cancer	0.000262	0.00059	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000262	0.00059	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000262	0.00059	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—urinary bladder cancer	0.000254	0.000572	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000253	0.000569	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000251	0.000564	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—urinary bladder cancer	0.000251	0.000564	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—urinary bladder cancer	0.000244	0.000548	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000243	0.000546	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000243	0.000546	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000242	0.000545	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—urinary bladder cancer	0.000238	0.000535	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—urinary bladder cancer	0.000235	0.000528	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—urinary bladder cancer	0.000234	0.000527	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000227	0.00051	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—urinary bladder cancer	0.000225	0.000507	CcSEcCtD
Acebutolol—Rash—Methotrexate—urinary bladder cancer	0.000223	0.000503	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—urinary bladder cancer	0.000223	0.000502	CcSEcCtD
Acebutolol—Headache—Methotrexate—urinary bladder cancer	0.000222	0.000499	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—urinary bladder cancer	0.00022	0.000495	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—urinary bladder cancer	0.000219	0.000493	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—urinary bladder cancer	0.000217	0.000488	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—urinary bladder cancer	0.000211	0.000474	CcSEcCtD
Acebutolol—Nausea—Methotrexate—urinary bladder cancer	0.00021	0.000473	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00021	0.000472	CcSEcCtD
Acebutolol—Rash—Epirubicin—urinary bladder cancer	0.000209	0.00047	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—urinary bladder cancer	0.000209	0.00047	CcSEcCtD
Acebutolol—Headache—Epirubicin—urinary bladder cancer	0.000208	0.000467	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—urinary bladder cancer	0.000203	0.000456	CcSEcCtD
Acebutolol—Nausea—Epirubicin—urinary bladder cancer	0.000197	0.000443	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—urinary bladder cancer	0.000195	0.000439	CcSEcCtD
Acebutolol—Rash—Doxorubicin—urinary bladder cancer	0.000193	0.000435	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000193	0.000435	CcSEcCtD
Acebutolol—Headache—Doxorubicin—urinary bladder cancer	0.000192	0.000432	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—urinary bladder cancer	0.000182	0.00041	CcSEcCtD
